[1]
F. A. Warid AL-Laftah, M. Elshafie, D. Alhashimi, and A. Pai, “Pretreatment Clinical Variables Associated With the Response to Intravitreal Bevacisumab (Avastin) Injection In Patients With Persistent Diabetic Macular Edema”, J Fac Med Baghdad, vol. 52, no. 2, pp. 142–146, Jul. 2010, doi: 10.32007/jfacmedbagdad.5221009.